Senior insider sale
REATA PHARMACEUTICALS INC — senior position signals high conviction
$1.35M
8.23K shares
What this filing means
RUFF SHAMIM plans to sell 8.23K shares of REATA PHARMACEUTICALS INC valued at approximately $1.35M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/28/2023ACC: 0001964306-23-000131
8.23K
Shares to sell
$1.35M
Approx. market value
8.23K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of employee stock options
Broker assisted cashless exercise
7/28/2023
8.23KTotal acquired8.23K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/28/2023 | Exercise of employee stock options Broker assisted cashless exercise | 8.23K | — |
| Total | 8.23K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
8.23K
Market value
$1.35M
7/28/2023
Total
Units
8.23K
Value
$1.35M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/28/2023 | 8.23K | $1.35M | NASDAQ | Planned |
| Total | 8.23K | $1.35M | ||